On December 17, 2010, the Court of Appeals for the Federal Circuit (CAFC) issued a decision in Prometheus Laboratories, Inc. v. Mayo Collaborative Services. This case was remanded to the CAFC from the Supreme Court for further consideration in light of the Court’s decision in Bilski v. Kappos. Following the remand, the CAFC affirmed their original decision in the case, reversing a District Court decision that found Prometheus’s diagnostic method to be patent-ineligible. The Federal Circuit once again ruled that Prometheus’s diagnostic method is patent-eligible subject matter under 35 USC § 101.
Please click here to read the CAFC decision.
Posted: December 17, 2010